|
muscle cell differentiation
|
GO:0042692 |
103 |
1.000
|
|
|
muscle structure development
|
GO:0061061 |
224 |
1.000
|
|
|
sarcomere organization
|
GO:0045214 |
26 |
1.000
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
90 |
0.999
|
|
|
myoblast fusion
|
GO:0007520 |
43 |
0.990
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.987
|
|
|
myofibril assembly
|
GO:0030239 |
36 |
0.983
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
43 |
0.970
|
|
|
somatic muscle development
|
GO:0007525 |
66 |
0.969
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
151 |
0.954
|
|
|
actin filament based process
|
GO:0030029 |
220 |
0.947
|
|
|
organelle assembly
|
GO:0070925 |
198 |
0.934
|
|
|
striated muscle cell development
|
GO:0055002 |
50 |
0.932
|
|
|
muscle cell development
|
GO:0055001 |
50 |
0.927
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
206 |
0.908
|
|
|
actin filament organization
|
GO:0007015 |
126 |
0.880
|
|
|
myotube differentiation
|
GO:0014902 |
46 |
0.855
|
|
|
mesoderm development
|
GO:0007498 |
78 |
0.756
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
3 |
0.714
|
|
|
imaginal disc derived wing morphogenesis
|
GO:0007476 |
337 |
0.693
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
89 |
0.641
|
|
|
regulation of protein polymerization
|
GO:0032271 |
28 |
0.640
|
|
|
muscle thin filament assembly
|
GO:0071689 |
5 |
0.634
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
25 |
0.624
|
|
|
muscle attachment
|
GO:0016203 |
36 |
0.616
|
|
|
cell motility
|
GO:0048870 |
251 |
0.581
|
|
|
protein complex biogenesis
|
GO:0070271 |
201 |
0.554
|
|
|
protein complex assembly
|
GO:0006461 |
200 |
0.543
|
|
|
cell migration
|
GO:0016477 |
238 |
0.472
|
|
|
macromolecular complex assembly
|
GO:0065003 |
256 |
0.459
|
|
|
cellular protein complex assembly
|
GO:0043623 |
71 |
0.439
|
|
|
positive regulation of actin filament polymerization
|
GO:0030838 |
11 |
0.401
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
6 |
0.400
|
|
|
tube development
|
GO:0035295 |
244 |
0.384
|
|
|
regulation of actin filament length
|
GO:0030832 |
27 |
0.382
|
|
|
regulation of wound healing
|
GO:0061041 |
13 |
0.361
|
|
|
muscle organ development
|
GO:0007517 |
127 |
0.361
|
|
|
regulation of cellular component size
|
GO:0032535 |
98 |
0.353
|
|
|
establishment of nucleus localization
|
GO:0040023 |
26 |
0.334
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
236 |
0.327
|
|
|
regulation of actin filament based process
|
GO:0032970 |
42 |
0.315
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
276 |
0.310
|
|
|
axon development
|
GO:0061564 |
297 |
0.309
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
153 |
0.299
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
242 |
0.298
|
|
|
nuclear division
|
GO:0000280 |
332 |
0.297
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
27 |
0.293
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
42 |
0.285
|
|
|
embryonic morphogenesis
|
GO:0048598 |
206 |
0.276
|
|
|
body morphogenesis
|
GO:0010171 |
2 |
0.272
|
|
|
muscle tissue development
|
GO:0060537 |
30 |
0.267
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.262
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
8 |
0.255
|
|
|
localization of cell
|
GO:0051674 |
257 |
0.254
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
1 |
0.253
|
|
|
open tracheal system development
|
GO:0007424 |
204 |
0.243
|
|
|
cell division
|
GO:0051301 |
248 |
0.241
|
|
|
skeletal muscle myosin thick filament assembly
|
GO:0030241 |
3 |
0.241
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
2 |
0.230
|
|
|
wing disc morphogenesis
|
GO:0007472 |
344 |
0.226
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
354 |
0.225
|
|
|
appendage morphogenesis
|
GO:0035107 |
397 |
0.224
|
|
|
negative regulation of protein depolymerization
|
GO:1901880 |
23 |
0.218
|
|
|
eye development
|
GO:0001654 |
323 |
0.213
|
|
|
neuron projection guidance
|
GO:0097485 |
241 |
0.212
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
174 |
0.208
|
|
|
axonogenesis
|
GO:0007409 |
290 |
0.207
|
|
|
protein depolymerization
|
GO:0051261 |
31 |
0.204
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
37 |
0.200
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
116 |
0.195
|
|
|
nucleus organization
|
GO:0006997 |
45 |
0.191
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
31 |
0.190
|
|
|
regulation of cell cycle
|
GO:0051726 |
291 |
0.190
|
|
|
cellular protein complex disassembly
|
GO:0043624 |
35 |
0.189
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
109 |
0.188
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
318 |
0.187
|
|
|
nuclear migration
|
GO:0007097 |
20 |
0.184
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
162 |
0.184
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.180
|
|
|
actin filament polymerization
|
GO:0030041 |
27 |
0.177
|
|
|
protein complex disassembly
|
GO:0043241 |
36 |
0.174
|
|
|
chemotaxis
|
GO:0006935 |
249 |
0.174
|
|
|
protein polymerization
|
GO:0051258 |
42 |
0.171
|
|
|
negative regulation of protein complex disassembly
|
GO:0043242 |
23 |
0.165
|
|
|
larval development
|
GO:0002164 |
104 |
0.165
|
|
|
imaginal disc derived appendage morphogenesis
|
GO:0035114 |
395 |
0.161
|
|
|
striated muscle adaptation
|
GO:0014888 |
1 |
0.161
|
|
|
heterocycle catabolic process
|
GO:0046700 |
166 |
0.161
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
414 |
0.161
|
|
|
digestive tract development
|
GO:0048565 |
149 |
0.159
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
83 |
0.158
|
|
|
nucleotide metabolic process
|
GO:0009117 |
161 |
0.156
|
|
|
regulation of organelle organization
|
GO:0033043 |
196 |
0.156
|
|
|
axon guidance
|
GO:0007411 |
233 |
0.153
|
|
|
establishment of oocyte nucleus localization involved in oocyte dorsal ventral axis specification
|
GO:0030722 |
6 |
0.153
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
316 |
0.149
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
97 |
0.149
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
146 |
0.149
|
|
|
regulation of muscle cell differentiation
|
GO:0051147 |
8 |
0.144
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
109 |
0.142
|
|
|
regulation of protein complex disassembly
|
GO:0043244 |
29 |
0.142
|
|
|
striated muscle tissue development
|
GO:0014706 |
27 |
0.140
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
119 |
0.135
|
|
|
myosin filament organization
|
GO:0031033 |
5 |
0.133
|
|
|
cell cycle phase transition
|
GO:0044770 |
140 |
0.133
|
|
|
negative regulation of actin filament depolymerization
|
GO:0030835 |
2 |
0.131
|
|
|
nucleus localization
|
GO:0051647 |
34 |
0.129
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
42 |
0.127
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
9 |
0.126
|
|
|
meiotic cell cycle
|
GO:0051321 |
171 |
0.126
|
|
|
tissue migration
|
GO:0090130 |
155 |
0.126
|
|
|
nucleotide catabolic process
|
GO:0009166 |
109 |
0.126
|
|
|
negative regulation of cytoskeleton organization
|
GO:0051494 |
30 |
0.124
|
|
|
muscle system process
|
GO:0003012 |
21 |
0.122
|
|
|
post embryonic appendage morphogenesis
|
GO:0035120 |
385 |
0.118
|
|
|
organelle localization
|
GO:0051640 |
148 |
0.117
|
|
|
organelle fission
|
GO:0048285 |
340 |
0.116
|
|
|
connective tissue development
|
GO:0061448 |
3 |
0.114
|
|
|
myosin filament assembly
|
GO:0031034 |
5 |
0.113
|
|
|
imaginal disc derived appendage development
|
GO:0048737 |
399 |
0.111
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
127 |
0.110
|
|
|
epithelial cell migration
|
GO:0010631 |
148 |
0.108
|
|
|
actin mediated cell contraction
|
GO:0070252 |
21 |
0.107
|
|
|
neurological system process
|
GO:0050877 |
358 |
0.106
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
119 |
0.106
|
|
|
mitotic nuclear division
|
GO:0007067 |
213 |
0.106
|
|
|
vesicle fusion
|
GO:0006906 |
19 |
0.105
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
50 |
0.104
|
|
|
central nervous system development
|
GO:0007417 |
201 |
0.103
|
|
|
growth
|
GO:0040007 |
359 |
0.102
|
|
|
determination of muscle attachment site
|
GO:0016204 |
7 |
0.102
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
168 |
0.102
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
332 |
0.101
|
|
|
actin filament bundle organization
|
GO:0061572 |
28 |
0.101
|
|
|
regulation of protein depolymerization
|
GO:1901879 |
27 |
0.099
|
|
|
catabolic process
|
GO:0009056 |
409 |
0.099
|
|
|
appendage development
|
GO:0048736 |
401 |
0.099
|
|
|
epithelial cell development
|
GO:0002064 |
274 |
0.098
|
|
|
organ growth
|
GO:0035265 |
56 |
0.098
|
|
|
cellular catabolic process
|
GO:0044248 |
372 |
0.097
|
|
|
regulation of catabolic process
|
GO:0009894 |
170 |
0.096
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
127 |
0.095
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
57 |
0.093
|
|
|
regulation of actin filament depolymerization
|
GO:0030834 |
3 |
0.093
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
382 |
0.093
|
|
|
organic substance catabolic process
|
GO:1901575 |
308 |
0.092
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
157 |
0.091
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
145 |
0.089
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
112 |
0.088
|
|
|
nucleobase containing compound catabolic process
|
GO:0034655 |
165 |
0.087
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
119 |
0.086
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
163 |
0.086
|
|
|
wound healing
|
GO:0042060 |
75 |
0.085
|
|
|
cytoplasmic transport
|
GO:0016482 |
130 |
0.085
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
45 |
0.084
|
|
|
positive regulation of phosphorus metabolic process
|
GO:0010562 |
139 |
0.083
|
|
|
small molecule metabolic process
|
GO:0044281 |
305 |
0.083
|
|
|
actin filament depolymerization
|
GO:0030042 |
5 |
0.082
|
|
|
response to wounding
|
GO:0009611 |
94 |
0.082
|
|
|
oocyte maturation
|
GO:0001556 |
3 |
0.081
|
|
|
single organism catabolic process
|
GO:0044712 |
228 |
0.081
|
|
|
multi organism behavior
|
GO:0051705 |
175 |
0.081
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
260 |
0.081
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
48 |
0.080
|
|
|
digestive system development
|
GO:0055123 |
149 |
0.078
|
|
|
nucleoside catabolic process
|
GO:0009164 |
112 |
0.077
|
|
|
sensory perception
|
GO:0007600 |
196 |
0.077
|
|
|
positive regulation of atp catabolic process
|
GO:1903291 |
3 |
0.077
|
|
|
carboxylic acid metabolic process
|
GO:0019752 |
92 |
0.076
|
|
|
positive regulation of gene expression
|
GO:0010628 |
290 |
0.076
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
156 |
0.076
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
112 |
0.076
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
47 |
0.076
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
130 |
0.075
|
|
|
spermatogenesis
|
GO:0007283 |
200 |
0.073
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
145 |
0.073
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
152 |
0.072
|
|
|
larval somatic muscle development
|
GO:0007526 |
19 |
0.072
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
72 |
0.072
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
217 |
0.071
|
|
|
positive regulation of catalytic activity
|
GO:0043085 |
118 |
0.070
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
210 |
0.070
|
|
|
columnar cuboidal epithelial cell development
|
GO:0002066 |
249 |
0.070
|
|
|
multi multicellular organism process
|
GO:0044706 |
123 |
0.069
|
|
|
regulation of cell death
|
GO:0010941 |
173 |
0.068
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
55 |
0.067
|
|
|
organophosphate metabolic process
|
GO:0019637 |
195 |
0.067
|
|
|
ameboidal type cell migration
|
GO:0001667 |
151 |
0.066
|
|
|
intracellular signal transduction
|
GO:0035556 |
300 |
0.066
|
|
|
cell adhesion
|
GO:0007155 |
136 |
0.065
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
78 |
0.065
|
|
|
cytoplasmic transport nurse cell to oocyte
|
GO:0007303 |
12 |
0.065
|
|
|
positive regulation of phosphate metabolic process
|
GO:0045937 |
139 |
0.065
|
|
|
regulation of catalytic activity
|
GO:0050790 |
185 |
0.064
|
|
|
negative regulation of gene expression
|
GO:0010629 |
387 |
0.064
|
|
|
positive regulation of molecular function
|
GO:0044093 |
136 |
0.064
|
|
|
protein localization
|
GO:0008104 |
284 |
0.063
|
|
|
molting cycle
|
GO:0042303 |
56 |
0.063
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
112 |
0.063
|
|
|
protein modification process
|
GO:0036211 |
438 |
0.063
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
112 |
0.063
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
48 |
0.063
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
145 |
0.062
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
155 |
0.061
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
108 |
0.061
|
|
|
larval visceral muscle development
|
GO:0007523 |
9 |
0.060
|
|
|
positive regulation of protein polymerization
|
GO:0032273 |
14 |
0.059
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
109 |
0.059
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
165 |
0.058
|
|
|
response to reactive oxygen species
|
GO:0000302 |
24 |
0.058
|
|
|
heart process
|
GO:0003015 |
37 |
0.058
|
|
|
response to nutrient levels
|
GO:0031667 |
114 |
0.058
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
108 |
0.057
|
|
|
atp metabolic process
|
GO:0046034 |
49 |
0.057
|
|
|
endocytosis
|
GO:0006897 |
310 |
0.057
|
|
|
ovarian follicle cell development
|
GO:0030707 |
248 |
0.056
|
|
|
regulation of myoblast fusion
|
GO:1901739 |
6 |
0.055
|
|
|
heart development
|
GO:0007507 |
82 |
0.055
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
105 |
0.054
|
|
|
cellular response to chemical stimulus
|
GO:0070887 |
199 |
0.054
|
|
|
cuticle development
|
GO:0042335 |
86 |
0.054
|
|
|
protein catabolic process
|
GO:0030163 |
101 |
0.053
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
405 |
0.053
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
22 |
0.053
|
|
|
cellular component disassembly
|
GO:0022411 |
46 |
0.053
|
|
|
wnt signaling pathway
|
GO:0016055 |
98 |
0.053
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
46 |
0.053
|
|
|
response to temperature stimulus
|
GO:0009266 |
106 |
0.052
|
|
|
heart morphogenesis
|
GO:0003007 |
32 |
0.052
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
120 |
0.051
|
|
|
muscle organ morphogenesis
|
GO:0048644 |
7 |
0.051
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
190 |
0.051
|
|
|
regulation of cell differentiation
|
GO:0045595 |
302 |
0.050
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
112 |
0.050
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
166 |
0.050
|
|
|
oxoacid metabolic process
|
GO:0043436 |
103 |
0.050
|
|
|
embryonic development via the syncytial blastoderm
|
GO:0001700 |
148 |
0.049
|
|
|
cellular amine metabolic process
|
GO:0044106 |
12 |
0.049
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
210 |
0.049
|
|
|
organic acid metabolic process
|
GO:0006082 |
103 |
0.048
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
45 |
0.047
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
62 |
0.047
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
39 |
0.047
|
|
|
chitin based cuticle development
|
GO:0040003 |
49 |
0.046
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
4 |
0.046
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
15 |
0.046
|
|
|
synapse organization
|
GO:0050808 |
196 |
0.045
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
108 |
0.045
|
|
|
positive regulation of cellular biosynthetic process
|
GO:0031328 |
316 |
0.045
|
|
|
cell chemotaxis
|
GO:0060326 |
6 |
0.044
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
97 |
0.044
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
201 |
0.044
|
|
|
regulation of apoptotic process
|
GO:0042981 |
130 |
0.044
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
62 |
0.043
|
|
|
translation
|
GO:0006412 |
69 |
0.043
|
|
|
apoptotic process
|
GO:0006915 |
159 |
0.043
|
|
|
meiotic nuclear division
|
GO:0007126 |
151 |
0.042
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
80 |
0.042
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
127 |
0.042
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
100 |
0.041
|
|
|
myotube cell development
|
GO:0014904 |
3 |
0.041
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
109 |
0.041
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
2 |
0.041
|
|
|
circulatory system development
|
GO:0072359 |
82 |
0.040
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
65 |
0.040
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
65 |
0.040
|
|
|
regulation of cell matrix adhesion
|
GO:0001952 |
1 |
0.040
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
56 |
0.039
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
45 |
0.039
|
|
|
macromolecule catabolic process
|
GO:0009057 |
161 |
0.038
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
256 |
0.038
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
21 |
0.037
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
31 |
0.037
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
57 |
0.037
|
|
|
border follicle cell migration
|
GO:0007298 |
113 |
0.036
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
22 |
0.036
|
|
|
regulation of programmed cell death
|
GO:0043067 |
152 |
0.036
|
|
|
locomotory behavior
|
GO:0007626 |
176 |
0.036
|
|
|
molting cycle chitin based cuticle
|
GO:0007591 |
56 |
0.036
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
283 |
0.035
|
|
|
tissue morphogenesis
|
GO:0048729 |
297 |
0.035
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
127 |
0.035
|
|
|
organelle fusion
|
GO:0048284 |
46 |
0.035
|
|
|
ovulation
|
GO:0030728 |
4 |
0.035
|
|
|
cytoskeleton dependent cytokinesis
|
GO:0061640 |
81 |
0.035
|
|
|
atp catabolic process
|
GO:0006200 |
38 |
0.035
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
110 |
0.034
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
22 |
0.034
|
|
|
ovarian follicle cell migration
|
GO:0007297 |
121 |
0.033
|
|
|
phagocytosis
|
GO:0006909 |
215 |
0.033
|
|
|
response to inorganic substance
|
GO:0010035 |
44 |
0.033
|
|
|
positive regulation of transcription from rna polymerase ii promoter
|
GO:0045944 |
204 |
0.033
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
3 |
0.033
|
|
|
response to extracellular stimulus
|
GO:0009991 |
116 |
0.033
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
80 |
0.033
|
|
|
axonal fasciculation
|
GO:0007413 |
12 |
0.033
|
|
|
epithelial cell differentiation
|
GO:0030855 |
322 |
0.032
|
|
|
compound eye development
|
GO:0048749 |
307 |
0.032
|
|
|
regionalization
|
GO:0003002 |
416 |
0.032
|
|
|
nephron development
|
GO:0072006 |
3 |
0.032
|
|
|
maintenance of location
|
GO:0051235 |
73 |
0.031
|
|
|
regulation of mitosis
|
GO:0007088 |
56 |
0.031
|
|
|
actin filament capping
|
GO:0051693 |
2 |
0.031
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
108 |
0.031
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
261 |
0.031
|
|
|
lipid storage
|
GO:0019915 |
38 |
0.030
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
142 |
0.030
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
55 |
0.030
|
|
|
stem cell differentiation
|
GO:0048863 |
117 |
0.030
|
|
|
taxis
|
GO:0042330 |
304 |
0.030
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
38 |
0.029
|
|
|
regulation of growth
|
GO:0040008 |
233 |
0.029
|
|
|
response to purine containing compound
|
GO:0014074 |
12 |
0.029
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
63 |
0.028
|
|
|
positive regulation of nucleic acid templated transcription
|
GO:1903508 |
266 |
0.028
|
|
|
regulation of molecular function
|
GO:0065009 |
217 |
0.028
|
|
|
cell substrate adhesion
|
GO:0031589 |
10 |
0.028
|
|
|
adult behavior
|
GO:0030534 |
137 |
0.028
|
|
|
regulation of proteolysis
|
GO:0030162 |
87 |
0.027
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
145 |
0.027
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
93 |
0.027
|
|
|
vesicle mediated transport
|
GO:0016192 |
381 |
0.027
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
2 |
0.027
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
138 |
0.027
|
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
87 |
0.027
|
|
|
anion homeostasis
|
GO:0055081 |
3 |
0.026
|
|
|
stem cell development
|
GO:0048864 |
79 |
0.026
|
|
|
response to endogenous stimulus
|
GO:0009719 |
119 |
0.026
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
50 |
0.026
|
|
|
cytokinesis
|
GO:0000910 |
90 |
0.026
|
|
|
response to organophosphorus
|
GO:0046683 |
2 |
0.025
|
|
|
centrosome organization
|
GO:0051297 |
163 |
0.025
|
|
|
visceral muscle development
|
GO:0007522 |
14 |
0.025
|
|
|
camera type eye development
|
GO:0043010 |
4 |
0.025
|
|
|
extracellular structure organization
|
GO:0043062 |
46 |
0.025
|
|
|
cell cycle arrest
|
GO:0007050 |
4 |
0.025
|
|
|
chromosome segregation
|
GO:0007059 |
157 |
0.024
|
|
|
defense response
|
GO:0006952 |
300 |
0.024
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
88 |
0.024
|
|
|
regulation of cell cycle process
|
GO:0010564 |
181 |
0.024
|
|
|
positive regulation of cell death
|
GO:0010942 |
69 |
0.024
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
378 |
0.024
|
|
|
regulation of blood circulation
|
GO:1903522 |
21 |
0.024
|
|
|
developmental maturation
|
GO:0021700 |
172 |
0.024
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
136 |
0.024
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
103 |
0.023
|
|
|
skeletal muscle organ development
|
GO:0060538 |
48 |
0.023
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
41 |
0.023
|
|
|
organophosphate catabolic process
|
GO:0046434 |
112 |
0.023
|
|
|
microtubule depolymerization
|
GO:0007019 |
25 |
0.023
|
|
|
nucleoside metabolic process
|
GO:0009116 |
127 |
0.023
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
3 |
0.023
|
|
|
regulation of immune system process
|
GO:0002682 |
176 |
0.023
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
64 |
0.023
|
|
|
homeostatic process
|
GO:0042592 |
199 |
0.023
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
27 |
0.023
|
|
|
chromosome organization
|
GO:0051276 |
360 |
0.023
|
|
|
mapk cascade
|
GO:0000165 |
107 |
0.023
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
51 |
0.022
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
130 |
0.022
|
|
|
regulation of system process
|
GO:0044057 |
36 |
0.022
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
58 |
0.022
|
|
|
response to abiotic stimulus
|
GO:0009628 |
341 |
0.022
|
|
|
dopamine biosynthetic process
|
GO:0042416 |
3 |
0.022
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
51 |
0.022
|
|
|
striated muscle contraction
|
GO:0006941 |
5 |
0.022
|
|
|
regulation of chromosome segregation
|
GO:0051983 |
32 |
0.022
|
|
|
cellular response to ethanol
|
GO:0071361 |
4 |
0.021
|
|
|
negative regulation of microtubule depolymerization
|
GO:0007026 |
21 |
0.021
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
44 |
0.021
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
128 |
0.021
|
|
|
regulation of cell adhesion
|
GO:0030155 |
27 |
0.021
|
|
|
cellular response to starvation
|
GO:0009267 |
61 |
0.021
|
|
|
spindle assembly involved in mitosis
|
GO:0090307 |
50 |
0.021
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
2 |
0.021
|
|
|
transmembrane transport
|
GO:0055085 |
139 |
0.021
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
3 |
0.021
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
256 |
0.021
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
121 |
0.020
|
|
|
cardiovascular system development
|
GO:0072358 |
82 |
0.020
|
|
|
skin development
|
GO:0043588 |
65 |
0.020
|
|
|
kidney development
|
GO:0001822 |
3 |
0.020
|
|
|
heart contraction
|
GO:0060047 |
26 |
0.020
|
|
|
chaperone mediated protein folding
|
GO:0061077 |
2 |
0.020
|
|
|
single organism intracellular transport
|
GO:1902582 |
207 |
0.020
|
|
|
cellular macromolecule localization
|
GO:0070727 |
220 |
0.020
|
|
|
rna processing
|
GO:0006396 |
147 |
0.020
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
265 |
0.019
|
|
|
blood circulation
|
GO:0008015 |
26 |
0.019
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
270 |
0.019
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
46 |
0.019
|
|
|
actin filament bundle assembly
|
GO:0051017 |
26 |
0.019
|
|
|
epithelium migration
|
GO:0090132 |
148 |
0.019
|
|
|
brain development
|
GO:0007420 |
120 |
0.019
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
50 |
0.019
|
|
|
oxidoreduction coenzyme metabolic process
|
GO:0006733 |
2 |
0.019
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
61 |
0.019
|
|
|
neuron recognition
|
GO:0008038 |
101 |
0.019
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
93 |
0.018
|
|
|
positive regulation of cell motility
|
GO:2000147 |
3 |
0.018
|
|
|
mitochondrion morphogenesis
|
GO:0070584 |
8 |
0.018
|
|
|
endodermal cell differentiation
|
GO:0035987 |
3 |
0.018
|
|
|
programmed cell death
|
GO:0012501 |
257 |
0.018
|
|
|
adult heart development
|
GO:0007512 |
1 |
0.018
|
|
|
oocyte nucleus localization involved in oocyte dorsal ventral axis specification
|
GO:0051663 |
12 |
0.017
|
|
|
establishment of chromosome localization
|
GO:0051303 |
20 |
0.017
|
|
|
positive regulation of developmental process
|
GO:0051094 |
143 |
0.017
|
|
|
eye morphogenesis
|
GO:0048592 |
260 |
0.017
|
|
|
response to hypoxia
|
GO:0001666 |
53 |
0.017
|
|
|
regulation of microtubule polymerization or depolymerization
|
GO:0031110 |
27 |
0.017
|
|
|
protein ubiquitination
|
GO:0016567 |
70 |
0.017
|
|
|
cellular protein modification process
|
GO:0006464 |
438 |
0.016
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
118 |
0.016
|
|
|
gonad development
|
GO:0008406 |
50 |
0.016
|
|
|
spermatid development
|
GO:0007286 |
98 |
0.016
|
|
|
negative regulation of microtubule polymerization or depolymerization
|
GO:0031111 |
21 |
0.016
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
167 |
0.016
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
1 |
0.016
|
|
|
regulation of cell division
|
GO:0051302 |
72 |
0.016
|
|
|
neuronal action potential
|
GO:0019228 |
10 |
0.016
|
|
|
tube morphogenesis
|
GO:0035239 |
191 |
0.016
|
|
|
response to organonitrogen compound
|
GO:0010243 |
75 |
0.016
|
|
|
compound eye morphogenesis
|
GO:0001745 |
249 |
0.016
|
|
|
kinetochore organization
|
GO:0051383 |
9 |
0.015
|
|
|
male mating behavior
|
GO:0060179 |
70 |
0.015
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
4 |
0.015
|
|
|
cell death
|
GO:0008219 |
279 |
0.015
|
|
|
death
|
GO:0016265 |
284 |
0.015
|
|
|
cellular homeostasis
|
GO:0019725 |
80 |
0.015
|
|
|
negative regulation of cell size
|
GO:0045792 |
19 |
0.015
|
|
|
regulation of sequestering of calcium ion
|
GO:0051282 |
3 |
0.015
|
|
|
regulation of localization
|
GO:0032879 |
275 |
0.015
|
|
|
organ formation
|
GO:0048645 |
39 |
0.014
|
|
|
cell recognition
|
GO:0008037 |
102 |
0.014
|
|
|
nicotinamide nucleotide metabolic process
|
GO:0046496 |
2 |
0.014
|
|
|
cell cycle checkpoint
|
GO:0000075 |
95 |
0.014
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
109 |
0.014
|
|
|
rho protein signal transduction
|
GO:0007266 |
14 |
0.014
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
108 |
0.014
|
|
|
microtubule organizing center organization
|
GO:0031023 |
168 |
0.014
|
|
|
response to calcium ion
|
GO:0051592 |
1 |
0.014
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
4 |
0.014
|
|
|
response to glucose
|
GO:0009749 |
2 |
0.014
|
|
|
regulation of neuron death
|
GO:1901214 |
26 |
0.014
|
|
|
positive regulation of signal transduction
|
GO:0009967 |
223 |
0.014
|
|
|
tube fusion
|
GO:0035146 |
17 |
0.014
|
|
|
mitotic sister chromatid separation
|
GO:0051306 |
30 |
0.014
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
81 |
0.014
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
43 |
0.014
|
|
|
formation of anatomical boundary
|
GO:0048859 |
37 |
0.014
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
38 |
0.014
|
|
|
cell cell adhesion mediated by integrin
|
GO:0033631 |
1 |
0.014
|
|
|
histone modification
|
GO:0016570 |
106 |
0.014
|
|
|
regulation of peptidase activity
|
GO:0052547 |
39 |
0.014
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
16 |
0.014
|
|
|
spindle elongation
|
GO:0051231 |
83 |
0.013
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
30 |
0.013
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
95 |
0.013
|
|
|
rhabdomere development
|
GO:0042052 |
38 |
0.013
|
|
|
urogenital system development
|
GO:0001655 |
72 |
0.013
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
42 |
0.013
|
|
|
respiratory system development
|
GO:0060541 |
213 |
0.013
|
|
|
negative regulation of fibroblast growth factor receptor signaling pathway
|
GO:0040037 |
2 |
0.013
|
|
|
establishment of localization in cell
|
GO:0051649 |
402 |
0.013
|
|
|
embryonic organ development
|
GO:0048568 |
50 |
0.013
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
0 |
0.013
|
|
|
positive regulation of transcription dna templated
|
GO:0045893 |
266 |
0.013
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
163 |
0.013
|
|
|
glial cell development
|
GO:0021782 |
27 |
0.013
|
|
|
response to heat
|
GO:0009408 |
63 |
0.013
|
|
|
lipid biosynthetic process
|
GO:0008610 |
46 |
0.013
|
|
|
embryonic pattern specification
|
GO:0009880 |
174 |
0.013
|
|
|
negative regulation of actin filament polymerization
|
GO:0030837 |
7 |
0.013
|
|